Watchlist Price Alert

Galectin Therapeutics Inc... (GALT)

NASDAQ: GALT · Real-Time Price · USD

3.29

0.90 (37.66%)

At close: Jun 18, 2025, 3:59 PM

3.26

-0.91%

After-hours: Jun 18, 2025, 07:59 PM EDT

Galectin Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-9.63M	-11.97M	-11.22M	-12.37M	-11.49M	-10M	-10.43M	-9.11M	-11.53M	-10.63M	-8.6M	-9.61M	-9.93M	-7.22M	-8.52M	-8.45M	-6.34M	-7.85M	-5.94M	-6.11M	-3.56M	-5.14M	-2.78M	-3M	-2.38M	-3.05M	-2.75M	-3.84M	-4.26M	-2.38M	-4.41M	-4.51M	-4.94M	-4.59M	-4.53M	-5.52M	-6.8M
Depreciation & Amortization	10K	10K	9K	9K	9K	9K	8K	-16K	32K	8K	7K	7K	10K	11K	10K	10K	10K	9K	10K	8K	9K	9K	8K	8K	10K	1K	n/a	n/a	n/a	n/a	n/a	n/a	1K	2K	2K	2K	1K
Stock-Based Compensation	468K	590K	515K	738K	604K	497K	586K	516K	662K	681K	681K	647K	858K	654K	587K	581K	254K	567K	408K	394K	430K	414K	414K	443K	412K	1.15M	663K	1.44M	1.19M	272K	230K	269K	330K	478K	376K	402K	1.22M
Other Working Capital	n/a	847K	-672K	1.24M	988K	-143K	894K	757K	499K	-496K	468K	445K	307K	-860K	396K	298K	289K	-697K	-975K	204K	173K	-64K	469K	197K	-137K	-190K	424K	-770K	81K	-1M	1.05M	-767K	79K	-754K	704K	505K	129K
Other Non-Cash Items	n/a	-1.75M	3M	141K	1.08M	-145K	682K	169K	913K	-143K	342K	-197K	-149K	-204K	12K	257K	22K	23K	21K	21K	22K	22K	418K	20K	-373K	80K	88K	88K	91K	18K	9K	4K	14K	n/a	376K	402K	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-490K	n/a	n/a	n/a	n/a	n/a	n/a	166K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-376K	-402K	n/a
Change in Working Capital	n/a	326K	-845K	3.15M	-2.31M	4.93M	1.51M	-898K	-873K	2.85M	-780K	1.73M	1.17M	-191K	2.75M	1.62M	-330K	1.84M	-2.71M	3.09M	-1.28M	933K	469K	197K	-958K	-190K	424K	-770K	-536K	-1.81M	1.05M	-767K	729K	-754K	704K	505K	2.09M
Operating Cash Flow	-7.69M	-12.79M	-8.54M	-8.33M	-12.11M	-4.7M	-7.64M	-9.83M	-10.79M	-7.24M	-8.35M	-7.43M	-8.04M	-6.95M	-5M	-5.98M	-6.38M	-5.41M	-8.21M	-2.6M	-4.37M	-3.76M	-1.48M	-2.33M	-3.28M	-2.01M	-1.58M	-3.08M	-3.52M	-3.9M	-3.12M	-5M	-3.86M	-4.87M	-3.44M	-4.61M	-3.49M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	10M	10M	10M	n/a	10M	10M	10M	n/a	n/a	n/a	10M	10M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	568K	n/a	277K	374K	n/a	n/a	n/a	899K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	-62K	n/a	-18K	n/a	n/a	n/a	n/a	n/a	n/a	-48K	n/a	n/a	-49K	n/a	n/a	n/a	-67K	-137K	n/a	n/a	-60K	-394K	-394K	n/a	-395K	-1.23M	n/a	n/a	-353K	-1.23M	n/a	n/a	-339K	n/a	n/a	n/a	-220K
Other Financial Acitivies	n/a	851K	10.02M	376K	n/a	n/a	10.03M	n/a	n/a	48K	n/a	n/a	n/a	n/a	n/a	10M	67K	137K	n/a	n/a	60K	394K	n/a	n/a	395K	1.23M	n/a	n/a	353K	1.23M	n/a	n/a	339K	-1.5M	1.5M	n/a	220K
Financial Cash Flow	n/a	851K	10M	10.38M	10M	10M	10.03M	10M	10M	10M	n/a	n/a	n/a	10M	10M	16.82M	n/a	n/a	n/a	44K	219K	902K	-231K	47.4M	2M	124K	1.22M	9.59M	4.45M	-1K	954K	485K	2.15M	4.17M	1.5M	257K	n/a
Net Cash Flow	-7.69M	-11.94M	1.46M	2.04M	-2.1M	5.3M	2.4M	-33K	-593K	2.76M	-8.35M	-7.43M	-8.04M	3.05M	5M	10.84M	-6.38M	-5.41M	-8.21M	-2.56M	-4.15M	-2.86M	-1.71M	45.07M	-1.28M	-1.88M	-361K	6.51M	935K	-3.9M	-2.17M	-4.52M	-1.72M	-697K	-1.94M	-4.35M	-3.49M
Free Cash Flow	-7.69M	-12.79M	-8.54M	-8.33M	-12.11M	-4.7M	-7.64M	-9.83M	-10.79M	-7.24M	-8.35M	-7.43M	-8.04M	-6.95M	-5M	-5.98M	-6.38M	-5.41M	-8.21M	-2.6M	-4.37M	-3.76M	-1.48M	-2.33M	-3.28M	-2.01M	-1.58M	-3.08M	-3.52M	-3.9M	-3.12M	-5M	-3.86M	-4.87M	-3.44M	-4.61M	-3.49M